Logo-ajcmi
Submitted: 18 Feb 2021
Accepted: 24 Nov 2021
ePublished: 29 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Avicenna J Clin Microbiol Infect. 2021;8(4): 164-172.
doi: 10.34172/ajcmi.2021.29
  Abstract View: 679
  PDF Download: 488

Review Article

Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From SARS and MERS

Mobina Fathi 1* ORCID logo, Kimia Vakili 1, Ramtin Hajibeygi 2, Niloofar Deravi 1*, Arian Tavasol 1 ORCID logo, Shirin Yaghoobpoor 1, Elahe Ahsan 1, Melika Mokhtari 3, Tara Fazel 4, Nazila Kassaian 5

1 Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Cardiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
3 Student Research Committee, Faculty of Dentistry, Tehran Medical sciences, Islamic Azad University, Tehran, Iran
4 Student Research Committee, School of International Campus, Guilan University of Medical Sciences, Rasht, Iran
5 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
*Corresponding Authors: *Corresponding author: Mobina Fathi, MD: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tel: +98 21 23871, Mobile: +98 9129612934, Email: , Email: mobina.fathi78@gmail.com; *Corresponding author: Niloofar Deravi, MD: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tel: +98 21 23871, Mobile: +98 9193195717, Email: , Email: niloofar.deravi@gmail.com

Abstract

For the last three decades, the world population has experienced new epidemics of coronaviruses. The world is currently witnessing the novel coronavirus disease (COVID-19) epidemic, which is a disease that comes from a novel coronavirus called Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The available genetic and clinical proofs suggest a similar route to those of Middle East respiratory syndrome (MERS) and SARS. The clinical manifestations of infections caused by coronaviruses including SARS, MERS, and COVID-19 are pneumonia, bronchitis, or other serious respiratory infections. Various transmission ways (e.g., nosocomial transmission) and transmission through moderately symptomatic or non-symptomatic infected individuals have caused great concerns. Although no certain treatment has so far been developed for this disease, and prevention is the main applied strategy for these viruses, some medications can be used to help with this disease. Corticosteroids can be mentioned as an example of these medications. This article specifically reviewed the evidence regarding the effectiveness of the corticosteroid therapy for the coronavirus family (i.e., SARS, MERS, and COVID-19) and showed that there are insufficient data to recommend corticosteroid therapy for patients suffering from COVID-19.


First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 680

Your browser does not support the canvas element.


PDF Download: 488

Your browser does not support the canvas element.